The Federal Government has announced the shutdown of 6 pharmaceutical manufacturing companies for non-compliance with Good Manufacturing Practice (GMP) of the National Agency for Food, Drug Administration and Control (NAFDAC).
This was disclosed by NAFDAC’s DG, Prof. Mojisola Adeyeye, in a statement on Monday, in Abuja.
Prof. Adeyeye said that NAFDAC acted in line with its policy of zero tolerance for the circulation of substandard and falsified medicines in the country.
- “The Pharmaceutical companies were shut down following nationwide surveillance of their manufacturing activities. These local manufacturers, in spite of appropriate notification, failed to meet minimum Good Manufacturing Practice (GMP) standards in line with extant requirements to assure the quality, safety and efficacy of Pharmaceutical products.
The DG said criminal non-regulatory activities by some drug makers were also discovered, following the surveillance exercise.
Prof. Adeyeye also stated that shutting down the 6 pharmaceutical companies’ operations should serve as a warning to other companies that failed to meet the GMP requirements, and added that companies that had been shut down would remain closed until they meet the full requirements.
- Nairametrics reported last month that Prof. Adeyeye said the agency had blacklisted Mars Remedies PVT Limited, India.
- The agency said the Indian company violated the NAFDAC Act, noting with dismay that it displayed a flagrant disregard for compliance with global standards necessary to assure the production of quality assured products.